Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,400 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 5 February 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download: 

(PDF, 3MB, 197 pages)

 

Export 2449 results:
Author Title [ Type(Desc)] Year
Journal Article
N. M. Hawkins, Scholes, S., Bajekal, M., Love, H., O'Flaherty, M., Raine, R., and Capewell, S., Community care in England: reducing socioeconomic inequalities in heart failure, Circulation, vol. 126, pp. 1050-7, 2012.
L. T. A. Mounce, Price, S., Valderas, J. M., and Hamilton, W., Comorbid conditions delay diagnosis of colorectal cancer: a cohort study using electronic primary care records, Br J Cancer, vol. 116, pp. 1536-1543, 2017.
C. J. Crooks, West, J., and Card, T. R., Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding, Gastroenterology, vol. 144, pp. 1384-93, 1393.e1-2; quiz e18-9, 2013.
H. Li, Hodgson, E., Watson, L., Shukla, A., and Nelson, J. J., Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis, J Cancer Epidemiol, vol. 2012, p. 291704, 2012.
M. Feudjo-Tepie, Ferguson, S., Roddam, A., Taylor, A., Bayly, J., and Critchlow, C., Comorbidities, bone-sparing agent prescription history and their determinants among postmenopausal women in UK primary care settings: a retrospective database study, Arch Osteoporos, vol. 10, p. 41, 2015.
C. F. Kuo, Grainge, M. J., Mallen, C., Zhang, W., and Doherty, M., Comorbidities in patients with gout prior to and following diagnosis: case-control study, Ann Rheum Dis, vol. 75, pp. 210-7, 2016.
D. C. Perry, Bruce, C. E., Pope, D., Dangerfield, P., Platt, M. J., and Hall, A. J., Comorbidities in Perthes' disease: a case control study using the General Practice Research database, J Bone Joint Surg Br, vol. 94, pp. 1684-9, 2012.
M. A. Feudjo-Tepie, Le Roux, G., Beach, K. J., Bennett, D., and Robinson, N. J., Comorbidities of idiopathic thrombocytopenic purpura: a population-based study, Adv Hematol, vol. 2009, p. 963506, 2009.
F. Nyberg, Horne, L., Morlock, R., Nuevo, J., Storgard, C., Aiyer, L., Hines, D. M., Ansolabehere, X., and Chevalier, P., Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis, Adv Ther, vol. 33, pp. 1180-98, 2016.
M. Nowakowska, Zghebi, S. S., Ashcroft, D. M., Buchan, I., Chew-Graham, C., Holt, T., Mallen, C., van Marwijk, H., Peek, N., Perera-Salazar, R., Reeves, D., Rutter, M. K., Weng, S. F., Qureshi, N., Mamas, M. A., and Kontopantelis, E., The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort, BMC Med, vol. 17, p. 145, 2019.
I. J. Chou, Kuo, C. F., Tanasescu, R., Tench, C. R., Tiley, C. G., Constantinescu, C. S., and Whitehouse, W. P., Comorbidity in multiple sclerosis: its temporal relationships with disease onset and dose effect on mortality, Eur J Neurol, 2019.
R. G. de Jong, Gallagher, A. M., Herrett, E., Masclee, A. A., Janssen-Heijnen, M. L., and de Vries, F., Comparability of the age and sex distribution of the UK Clinical Practice Research Datalink and the total Dutch population, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1460-1464, 2016.
S. Khalid, Calderon-Larranaga, S., Hawley, S., Ali, M. S., Judge, A., Arden, N., Van Staa, T., Cooper, C., Javaid, M. K., and Prieto-Alhambra, D., Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database, Clin Epidemiol, vol. 10, pp. 1417-1431, 2018.
S. Toovey, Nieforth, K., Smith, P., Schlagenhauf, P., Adamcova, M., Tatt, I., Tomianovic, D., and Schnetzler, G., Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers, Travel Med Infect Dis, vol. 12, pp. 726-32, 2014.
S. Hennessy, Bilker, W. B., Knauss, J. S., Kimmel, S. E., Margolis, D. J., Morrison, M. F., Reynolds, R. F., Glasser, D. B., and Strom, B. L., Comparative cardiac safety of low-dose thioridazine and low-dose haloperidol, Br J Clin Pharmacol, vol. 58, pp. 81-7, 2004.
A. Douros, Dell'Aniello, S., Yu, O. H. Y., and Suissa, S., Comparative cardiovascular and hypoglycemic safety of glimepiride in type 2 diabetes: A population-based cohort study, Diabetes Obes Metab, 2019.
L. Sinyavskaya, Gauthier, S., Renoux, C., Dell'Aniello, S., Suissa, S., and Brassard, P., Comparative effect of statins on the risk of incident Alzheimer disease, Neurology, vol. 90, pp. e179-e187, 2018.
S. Suissa, Dell'Aniello, S., and Ernst, P., Comparative effectiveness and safety of LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice, Chest, 2019.
S. J. Sinnott, Smeeth, L., Williamson, E., Perel, P., Nitsch, D., Tomlinson, L. A., and Douglas, I. J., The comparative effectiveness of fourth-line drugs in resistant hypertension: An application in electronic health record data, Pharmacoepidemiol Drug Saf, 2019.
J. M. Gamble, Thomas, J. M., Twells, L. K., Midodzi, W. K., and Majumdar, S. R., Comparative effectiveness of incretin-based therapies and the risk of death and cardiovascular events in 38,233 metformin monotherapy users, Medicine (Baltimore), vol. 95, p. e3995, 2016.
S. Suissa, Dell'Aniello, S., and Ernst, P., Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study, Lancet Respir Med, vol. 6, pp. 855-862, 2018.
S. Y. Loo, Coulombe, J., Dell'Aniello, S., Brophy, J. M., Suissa, S., and Renoux, C., Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study, BMJ Open, vol. 8, p. e019638, 2018.
C. S. Murray, Thomas, M., Richardson, K., Price, D. B., and Turner, S. W., Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study, J Allergy Clin Immunol Pract, vol. 5, pp. 1082-1090.e7, 2017.
S. Suissa, Dell'Aniello, S., and Ernst, P., Comparative effects of LAMA-LABA-ICS versus LAMA-LABA for COPD: Cohort study in real world clinical practice: LAMA-LABA-ICS versus LAMA-LABA in COPD, Chest, 2019.
S. Wilkinson, Williamson, E., Pokrajac, A., Fogarty, D., Stirnadel-Farrant, H., Smeeth, L., Douglas, I. J., and Tomlinson, L. A., Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care, Diabetes Obes Metab, 2020.
E. Berni, Butler, C. C., Jenkins-Jones, S., de Voogd, H., Ouwens, M., Morgan, C. L., and Currie, C. J., Comparative estimated effectiveness of antibiotic classes as initial and secondary treatments of respiratory tract infections: longitudinal analysis of routine data from UK primary care 1991-2012, Curr Med Res Opin, vol. 32, pp. 1023-32, 2016.
H. A. van den Ham, Klungel, O. H., Singer, D. E., Leufkens, H. G., and van Staa, T. P., Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database, J Am Coll Cardiol, vol. 66, pp. 1851-9, 2015.
S. S. Zghebi, Steinke, D. T., Rutter, M. K., Emsley, R. A., and Ashcroft, D. M., Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records, Diabetes Obes Metab, vol. 18, pp. 916-24, 2016.
J. M. Gamble, Donnan, J. R., Chibrikov, E., Twells, L. K., Midodzi, W. K., and Majumdar, S. R., Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes, Sci Rep, vol. 8, p. 15142, 2018.
D. B. Price, Carter, V., Martin, J., Gardener, E. A., Skinner, D., Yang, S., Hoffman, M., Willis, J. C., and Cooper, A. J., Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting beta2-Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary Care, Drugs, 2019.
S. Borghs, Byram, L., Chan, J., Dedeken, P., Logan, J., Kiri, V., Noack-Rink, M., Patsalos, P. N., and Thieffry, S., Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study, BMC Neurol, vol. 20, p. 7, 2020.
S. L. Brilleman and Salisbury, C., Comparing measures of multimorbidity to predict outcomes in primary care: a cross sectional study, Fam Pract, vol. 30, pp. 172-8, 2013.
R. A. Charlton, Weil, J. G., Cunnington, M. C., Ray, S., and de Vries, C. S., Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations, Drug Saf, vol. 34, pp. 157-71, 2011.
J. Hoare, Comparison of area-based inequality measures and disease morbidity in England, 1994–1998., Health Stat Q, vol. 18, pp. 18-24, 2003.
C. S. Arhi, Bottle, A., Burns, E. M., Clarke, J. M., Aylin, P., Ziprin, P., and Darzi, A., Comparison of cancer diagnosis recording between the Clinical Practice Research Datalink, Cancer Registry and Hospital Episodes Statistics, Cancer Epidemiol, vol. 57, pp. 148-157, 2018.
R. D. Neal, Din, N. U., Hamilton, W., Ukoumunne, O. C., Carter, B., Stapley, S., and Rubin, G., Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database, Br J Cancer, vol. 110, pp. 584-92, 2014.
T. P. van Staa, Leufkens, H. G., Zhang, B., and Smeeth, L., A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example, PLoS Med, vol. 6, p. e1000194, 2009.
A. Brown, Kirichek, O., Balkwill, A., Reeves, G., Beral, V., Sudlow, C., Gallacher, J., and Green, J., Comparison of dementia recorded in routinely collected hospital admission data in England with dementia recorded in primary care, Emerg Themes Epidemiol, vol. 13, p. 11, 2016.
H. Strongman, D'Oca, K., Langerman, H., and Das, R., Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study, Diabetes Obes Metab, vol. 17, pp. 573-80, 2015.
H. Jick, Ulcickas, M., and Dean, A., Comparison of frequencies of suicidal tendencies among patients receiving fluoxetine, lofepramine, mianserin, or trazodone, Pharmacotherapy, vol. 12, pp. 451-4, 1992.
A. Ruigomez, Rodriguez, L. A. Garcia, Wallander, M. A., Johansson, S., and Dent, J., Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care, Curr Med Res Opin, vol. 22, pp. 1661-8, 2006.
T. Sheppard, Tamblyn, R., Abrahamowicz, M., Lunt, M., Sperrin, M., and Dixon, W. G., A comparison of methods for estimating the temporal change in a continuous variable: Example of HbA1c in patients with diabetes, Pharmacoepidemiol Drug Saf, vol. 26, pp. 1474-1482, 2017.
J. L. Hong, Webster-Clark, M., Funk, M. J., Sturmer, T., Dempster, S., Cole, S. R., Herr, I., and LoCasale, R., Comparison of Methods to Generalize Randomized Clinical Trial Results without Individual-Level Data for the Target Population, Am J Epidemiol, 2018.
L. A. Garcia Rodriguez, Ruigomez, A., Hasselgren, G., Wallander, M. A., and Johansson, S., Comparison of mortality from peptic ulcer bleed between patients with or without peptic ulcer antecedents, Epidemiology, vol. 9, pp. 452-6, 1998.
H. Jick, Wilson, A., Wiggins, P., and Chamberlain, D. P., Comparison of prescription drug costs in the United States and the United Kingdom, part 2: proton pump inhibitors, Pharmacotherapy, vol. 32, pp. 489-92, 2012.
L. Hassan, Senior, J., Frisher, M., Edge, D., and Shaw, J., A comparison of psychotropic medication prescribing patterns in East of England prisons and the general population, J Psychopharmacol, vol. 28, pp. 357-62, 2014.
T. P. van Staa, Setakis, E., Di Tanna, G. L., Lane, D. A., and Lip, G. Y., A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice, J Thromb Haemost, vol. 9, pp. 39-48, 2011.
C. B. Forrest, Majeed, A., Weiner, J. P., Carroll, K., and Bindman, A. B., Comparison of specialty referral rates in the United Kingdom and the United States: retrospective cohort analysis, Bmj, vol. 325, pp. 370-1, 2002.
S. De Wilde, Carey, I. M., Bremner, S. A., Richards, N., Hilton, S. R., Strachan, D. P., and Cook, D. G., A comparison of the recording of 30 common childhood conditions in the Doctor's Independent Network and General Practice Research Databases, Health Stat Q, pp. 21-31, 2004.
C. J. Crooks, West, J., and Card, T. R., A comparison of the recording of comorbidity in primary and secondary care by using the Charlson Index to predict short-term and long-term survival in a routine linked data cohort, BMJ Open, vol. 5, p. e007974, 2015.
[Page last reviewed 5 February 2020]